| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000014175 |
| Receipt No. | R000016510 |
| Official scientific title of the study | ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial |
| Date of disclosure of the study information | 2014/06/15 |
| Last modified on | 2016/06/05 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial | |
| Title of the study (Brief title) | ESSENSE protocol for peri-operative patients management; a multi-center prospective clinical trial | |
| Region |
|
|
| Condition | ||||
| Condition | Status after high-stress surgical procedure, such as esophagectomy, total or distal gastrectomy, colectomy, hepatectomy and pancreatico-duodenectomy. | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | ESSENSE protocol is extracted from Enhanced Recovery After Surgery (ERAS) protocol established in European society. The purpose of this study is to examine the effectiveness of ESSENSE protocol for the patients physical recovery after high-stress surgical treatment.
"ESSENSE" is an acronym of ESsential Strategy for Early Normalization after Surgery with patient's Excellent satisfaction. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II,III |
| Assessment | |
| Primary outcomes | Post-operative patients recovery estimated by QoR40 format in 3rd and 7th postoperative days. |
| Key secondary outcomes | Patient's physical condition estimated by blood test; Albumin, total lymphocyte count, sodium, C-reactive protein and total cholesterol. Number of complications.
Length of hospital stay after surgery. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Factorial |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients in the study group will be managed by ESSENSE protocol as indicated below for 6 months. Control group will be managed by standard care protocol in each hospital.
1. Intensive pain control: postoperative pain will be estimated by Prince Henry Hospital pain scale and pain must be reduced to be able enough to cough. 2. Minimization of fasting: 400ml clear fluid will be provided until 2hour before induction of anesthesia and restart drinking since 1st postoperative day. Amount of intake is recorded in ESSENSE diary by medical staff and patients themselves. 3. Early mobilization: walking around the bed is scheduled since 1st postoperative day. Count of steps walking is recorded in ESSENSE diary by patients. 4. Encourage the will of recovery: Physical condition will be conscious by recording ESSENSE diary that is a tool for sharing the goal and the process of recovery among medical staff and patients themselves. |
|
| Interventions/Control_2 | In contrast of ESSENSE protocol, control group patients will be managed by standard protocol. Pain killer will be administrated according to patient's complaints. Fasting in the day of the operation and restart drinking according to patient's bowel condition. Mobilization will be done voluntary. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who are judged as operable in the individual hospital. | |||
| Key exclusion criteria | 1.Patients unable to record their physical status in diary.
2.Patients unable to drink from before an operation. 3.Patients unable to walk from before an operation. |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Go Miyata |
| Organization | Tohoku University, Graduate School of Medicine |
| Division name | Division of Advanced Surgical Science and Technology |
| Address | Seiryo-machi 1-1, Aoba-ku, Sendai,city, Miyagi pref. JAPAN |
| TEL | +81-22-717-7214 |
| miyata5@med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Go Miyata |
| Organization | Japanese Society for Surgical metabolism and nutrition |
| Division name | Peri-operative management study group |
| Address | Shunkosha Co.Ltd. Ohkubo 2-4-12, Shinjuku-ku, Tokyo, JAPAN |
| TEL | +81-3-5291-6231 |
| Homepage URL | http://www.jsmmn.jp/essense/index.html |
| essense@shunkosha.com | |
| Sponsor | |
| Institute | Japanese Society for Surgical metabolism and nutrition |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Japanese Society for Surgical metabolism and nutrition |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学病院(宮城県)、浜松医療センター(静岡県)、下関医療センター(山口県)、埼玉医大国際医療センター(埼玉県)、小張総合病院(千葉県)、東邦大学医療センター大森病院(東京都)、関西医科大学(大阪府)、那須赤十字病院(栃木県)、横浜中央病院(神奈川県)、県立広島病院(広島県)、市立堺病院(大阪府)、東京慈恵会医科大学付属病院(東京都)、市立池田病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | http://www.jsmmn.jp/essense/index.html |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016510 |